International Burden of Cancer Deaths and Years of Life Lost from Cancer Attributable to Four Major Risk Factors: a Population-based Study in Brazil, Russia, India, China, South Africa, the United Kingdom, and United States

Overview

Journal EClinicalMedicine

Specialty General Medicine

Date 2024 Jan 9

PMID 38192589

Authors

Harriet Rumgay

Citadel J Cabasag

Judith Offman

Marianna de Camargo Cancela

Anton Barchuk

Prashant Mathur

Shaoming Wang

Wenqiang Wei

Peter Sasieni

Isabelle Soerjomataram

Affiliations

Soon will be listed here.

Abstract

Background: We provide a comprehensive view of the impact of alcohol consumption, tobacco smoking, excess body weight, and human papillomavirus (HPV) infection on cancer mortality and years of life lost (YLLs) in Brazil, Russia, India, China, South Africa, the United Kingdom (UK), and United States (US).

Methods: We collected population attributable fractions of the four risk factors from global population-based studies and applied these to estimates of cancer deaths in 2020 to obtain potentially preventable cancer deaths and their 95% confidence intervals (CIs). Using life tables, we calculated the number and age-standardised rates of YLLs (ASYR).

Findings: In Brazil, Russia, India, China, South Africa, the UK, and the US in 2020, an estimated 5.9 million (3.3 million-8.6 million) YLLs from cancer were attributable to alcohol consumption, 20.8 million (17.0 million-24.6 million) YLLs to tobacco smoking, 3.1 million (2.4 million-3.8 million) YLLs to excess body weight, and 4.0 million (3.9 million-4.2 million) YLLs to HPV infection. The ASYR from cancer due to alcohol consumption was highest in China (351.4 YLLs per 100,000 population [95% CI 194.5-519.2]) and lowest in the US (113.5 [69.6-157.1]) and India (115.4 [49.7-172.7). For tobacco smoking, China (1159.9 [950.6-1361.8]) had the highest ASYR followed by Russia (996.8 [831.0-1154.5). For excess body weight, Russia and the US had the highest ASYRs (385.1 [280.6-481.2] and 369.4 [299.6-433.6], respectively). The highest ASYR due to HPV infection was in South Africa (457.1 [453.3-462.6]). ASYRs for alcohol consumption and tobacco smoking were higher among men than women, whereas women had higher ASYRs for excess body weight and HPV infection.

Interpretation: Our findings demonstrate the importance of cancer control efforts to reduce the burden of cancer death and YLLs due to modifiable cancer risk factors and promote the use of YLLs to summarise disease burden.

Funding: Cancer Research UK.

Citing Articles

Are we ready? assessing effectiveness and implementation of cancer control strategies in primary care: a comprehensive review of systematic reviews.

Martinez-Gutierrez J, Soto M, Rioseco A, Bienzobas C, Fowler M, Ulloa G Fam Pract. 2025; 42(2).

PMID: 39918006 PMC: 11803426. DOI: 10.1093/fampra/cmae078.

Editorial: Current Approaches to Screening for Lung Cancer in Smokers and Non-Smokers.

Parums D Med Sci Monit. 2025; 31:e948255.

PMID: 39891449 PMC: 11796283. DOI: 10.12659/MSM.948255.

Navigating the Landscape of Cancer From Ancient Times to Modern Challenges: A Narrative Review.

Bhawalkar J, Nagar A, Rathod H, Verma P Cureus. 2024; 16(7):e65230.

PMID: 39184629 PMC: 11341954. DOI: 10.7759/cureus.65230.

Fractional order cancer model infection in human with CD8+ T cells and anti-PD-L1 therapy: simulations and control strategy.

Nisar K, Kulachi M, Ahmad A, Farman M, Saqib M, Saleem M Sci Rep. 2024; 14(1):16257.

PMID: 39009619 PMC: 11251283. DOI: 10.1038/s41598-024-66593-x.

Mathematical modeling and control of lung cancer with IL2 cytokine and anti-PD-L1 inhibitor effects for low immune individuals.

Ahmad A, Kulachi M, Farman M, Junjua M, Riaz M, Riaz S PLoS One. 2024; 19(3):e0299560.

PMID: 38483931 PMC: 10939278. DOI: 10.1371/journal.pone.0299560.

References

Ferreira A, Szwarcwald C, Damacena G, Souza Junior P . Increasing trends in obesity prevalence from 2013 to 2019 and associated factors in Brazil. Rev Bras Epidemiol. 2021; 24(suppl 2):e210009. DOI: 10.1590/1980-549720210009.supl.2. View

Li X, Galea G . Healthy China 2030: an opportunity for tobacco control. Lancet. 2019; 394(10204):1123-1125. DOI: 10.1016/S0140-6736(19)32048-3. View

. Chlorinated drinking-water; chlorination by-products; some other halogenated compounds; cobalt and cobalt compounds. International Agency for Research on Cancer (IARC) Working Group, Lyon, 12-19 June 1990. IARC Monogr Eval Carcinog Risks Hum. 1991; 52:1-544. PMC: 7681469. View

Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag C, Morrison D . Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019; 4(7):511-518. PMC: 7617144. DOI: 10.1016/S2468-1253(19)30147-5. View

Costa R, Longatto-Filho A, Vazquez F, Pinheiro C, Zeferino L, Fregnani J . Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013. BMC Cancer. 2018; 18(1):126. PMC: 5797416. DOI: 10.1186/s12885-018-4047-9. View

Shkolnikov V, Churilova E, Jdanov D, Shalnova S, Nilssen O, Kudryavtsev A . Time trends in smoking in Russia in the light of recent tobacco control measures: synthesis of evidence from multiple sources. BMC Public Health. 2020; 20(1):378. PMC: 7092419. DOI: 10.1186/s12889-020-08464-4. View

Silva L, Helman B, Luz E Silva D, Aquino E, de Freitas P, Santos R . Prevalence of heavy episodic drinking in the Brazilian adult population: National Health Survey 2013 and 2019. Epidemiol Serv Saude. 2022; 31(spe1):e2021379. PMC: 9897822. DOI: 10.1590/SS2237-9622202200003.especial. View

de Camargo Cancela M, Bezerra de Souza D, Leite Martins L, Borges L, Schilithz A, Hanly P . Can the sustainable development goals for cancer be met in Brazil? A population-based study. Front Oncol. 2023; 12:1060608. PMC: 9872119. DOI: 10.3389/fonc.2022.1060608. View

Tam J, Jaffri M, Mok Y, Jeon J, Szklo A, Souza M . Patterns of Birth Cohort‒Specific Smoking Histories in Brazil. Am J Prev Med. 2023; 64(4 Suppl 1):S63-S71. PMC: 10240503. DOI: 10.1016/j.amepre.2022.12.002. View

10.

Morgan E, Soerjomataram I, Gavin A, Rutherford M, Gatenby P, Bardot A . International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 2020; 70(2):234-242. DOI: 10.1136/gutjnl-2020-321089. View

11.

Arnold M, Pandeya N, Byrnes G, Renehan P, Stevens G, Ezzati P . Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2014; 16(1):36-46. PMC: 4314462. DOI: 10.1016/S1470-2045(14)71123-4. View

12.

Pearce A, Sharp L, Hanly P, Barchuk A, Bray F, de Camargo Cancela M . Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison. Cancer Epidemiol. 2018; 53:27-34. DOI: 10.1016/j.canep.2017.12.013. View

13.

Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F . Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 2023; 11(11):e1700-e1712. PMC: 10581909. DOI: 10.1016/S2214-109X(23)00406-0. View

14.

Bhatla N, Meena J, Kumari S, Banerjee D, Singh P, Natarajan J . Cervical Cancer Prevention Efforts in India. Indian J Gynecol Oncol. 2021; 19(3):41. PMC: 8170054. DOI: 10.1007/s40944-021-00526-8. View

15.

Aragon T, Lichtensztajn D, Katcher B, Reiter R, Katz M . Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death. BMC Public Health. 2008; 8:116. PMC: 2386472. DOI: 10.1186/1471-2458-8-116. View

16.

Martinez R, Soliz P, Caixeta R, Ordunez P . Reflection on modern methods: years of life lost due to premature mortality-a versatile and comprehensive measure for monitoring non-communicable disease mortality. Int J Epidemiol. 2019; 48(4):1367-1376. PMC: 6693813. DOI: 10.1093/ije/dyy254. View

17.

Ferlay J, Colombet M, Soerjomataram I, Parkin D, Pineros M, Znaor A . Cancer statistics for the year 2020: An overview. Int J Cancer. 2021; . DOI: 10.1002/ijc.33588. View

18.

Brown K, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A . The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018; 118(8):1130-1141. PMC: 5931106. DOI: 10.1038/s41416-018-0029-6. View

19.

Islami F, Sauer A, Miller K, Siegel R, Fedewa S, Jacobs E . Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2017; 68(1):31-54. DOI: 10.3322/caac.21440. View

20.

Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F . International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014; 84(1):13-22. DOI: 10.1016/j.lungcan.2014.01.009. View